Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Nevalainen, Pasi I ^a   Lahtela, Jorma T ^a,b   Mustonen, Jukka ^a,b   Pasternack, Amos ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Diabetes mellitus; Glucose metabolism; Insulin sensitivity; Intraperitoneal insulin; Serum lipids; Subcutaneous insulin; Uremia

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPHANE INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN HYPOGLYCEMIA; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029950752     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s54     Document Type: Conference Paper

References (11)

1. Khanna R, Oreopoulos DG. Peritoneal dialysis in diabetic end-stage renal disease. J Diabet Complications 1989; 3:12-17.
2. Selam J-L, Raccah D, Jean-Didier N, et al. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.Diabetes Care 1992; 15:53-8.
3. Lahtela JT, Mustonen J, Pasternack A. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment. Clin Sci 1995; 88:427-32.
4. Duckworth WC, Saudek CD, Henry RP. Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes 1992; 41:657-61.
5. Kazumi T, Vranic M, Bar-On H, Steiner G. Portal versus peripheral hyperinsulinemia and very low density lipoprotein triglyceride kinetics.Metabolism 1986; 35:1024-8.
6. Selam J-L, Kashyap M, Alberti KGMM,et al. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites and hormones in type I diabetes mellitus. Metabolism 1989; 38:908-12.
7. Ruotolo G, Parlavecchia M, Taskinen M-R, et al. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM: role of increased hepatic lipase activity. Diabetes Care 1994; 17:6-12.
8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-23.
9. Lipid Research Clinics Programme. Manual of laboratory operations, NIH publications no. 75-628. Bethesda, MD: National Institutes of Health, Education and Welfare, 1974:9-50.
10. Ruotolo G, Micossi P, Galimberti G, et al. Effects of intraperitoneal insulin administration on lipoprotein metabolism in type I diabetes. Metabolism 1990; 39:598-604.
11. Selam J-L, Kashyap ML, Gupta AK, et al. Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery. Metabolism 1994; 43:665-9.